Adapted Cognitive Behavioral Therapy for Insomnia in Teens
Official title: Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
Run by Indiana University · NCT06541886 · Data updated 2026-11-12
This study is testing a new version of therapy for insomnia designed for teens to see if it helps them sleep better compared to those who aren't getting the treatment right away.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 18 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | April 3, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT06541886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 13-18 who meet the diagnostic criteria for Chronic Insomnia Disorder.
✕Probably not a fit
Patients who do not have insomnia or those outside the specified age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate an adapted version of Cognitive Behavioral Therapy for Insomnia (CBT-I) specifically designed for adolescents, referred to as Teen CBT-I. The intervention will be compared to a waitlist control group to assess its effectiveness in reducing insomnia symptoms among teens aged 13-18. The adaptation process involved collaboration with teens, parents, and healthcare providers to ensure the treatment aligns with adolescent biology and lifestyles. Researchers will also assess the acceptability of Teen CBT-I from both teens and their parents.
Why it matters
Potential benefit: If successful, this treatment could significantly improve sleep quality and overall well-being for adolescents suffering from insomnia.
How similar studies have gone: Preliminary evidence suggests that adaptations of CBT-I for adolescents are promising, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents (13-18 years) who are in either middle school or high school and meet ICSD-3 diagnostic criteria for Chronic Insomnia Disorder, currently or in the past year, based on self-reported insomnia symptoms, using a screening checklist. * Reside in a state where Dr. McQuillan (supervising provider) is licensed to practice psychology (with PsyPact) which are the following states: Alabama, Arizona, Arkansas, Colorado, Commonwealth of the Northern Mariana Islands, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kentucky, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. * Sufficient English language proficiency for consent and study participation * Reliable internet access to attend virtual visits with audio and video * Parents or other caregivers of these adolescents (hereafter referred to as a parent) must live in the home with the identified adolescent at least 50% of the time and must report playing a parental role for that adolescent. The parent must also be able to attend the final 10 minutes of each treatment session, if the teen is randomized to a treatment condition. Exclusion Criteria: * Sleep aid use that is either inconsistent (e.g., used some but not all nights) and cannot be discontinued OR consistent and effective enough that the teen no longer has insomnia symptoms while using it. If a teen agrees to keep the dose and frequency of sleep aid use consistent throughout the treatment and still has insomnia symptoms at baseline, they are not ineligible. * Prior participation in Aim 1 of DREAM IT study (e.g., participation in an Aim 1 focus group). * Comorbid medical or psychiatric conditions, including substance use disorders, that are acute, unstable, or untreated. Individuals with Autism Spectrum Disorder, Epilepsy, Schizophrenia, and Bipolar Disorder will be excluded. * Comorbid delayed sleep wake phase disorder or other active/untreated sleep disorders, including RLS, OSA, and Nightmare disorder * Active suicidal ideation with plan and intent
Where it's running
-
Indiana University School of Medicine
Indianapolis, Indiana, United States Recruiting
Study contacts
- Principal investigator: Sarah M Honaker, PhD — Indiana University
- Study coordinator: Maureen E McQuillan, PhD
- Email: memcquil@iu.edu
- Phone: 317-944-7368
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.